Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Current Leases (2022 - 2025)

Historic Current Leases for Exagen (XGN) over the last 4 years, with Q3 2025 value amounting to $1.2 million.

  • Exagen's Current Leases rose 1192.49% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 1192.49%. This contributed to the annual value of $1.1 million for FY2024, which is 1229.51% up from last year.
  • As of Q3 2025, Exagen's Current Leases stood at $1.2 million, which was up 1192.49% from $1.2 million recorded in Q2 2025.
  • Exagen's Current Leases' 5-year high stood at $1.2 million during Q3 2025, with a 5-year trough of $949000.0 in Q1 2022.
  • Over the past 4 years, Exagen's median Current Leases value was $1.1 million (recorded in 2024), while the average stood at $1.1 million.
  • Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 1296.1% in 2023, then plummeted by 641.48% in 2024.
  • Quarter analysis of 4 years shows Exagen's Current Leases stood at $1.0 million in 2022, then decreased by 6.15% to $976000.0 in 2023, then grew by 12.3% to $1.1 million in 2024, then rose by 8.76% to $1.2 million in 2025.
  • Its Current Leases was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.1 million in Q1 2025.